반응식
[Cl:1][C:2]1[CH:8]=[CH:7][CH:6]=[C:5]([CH3:9])[C:3]=1[NH2:4].Cl[C:11]1[C:20]2[C:15](=[C:16]([O:23][CH:24]3[CH2:28][CH2:27][CH2:26][CH2:25]3)[C:17]([O:21][CH3:22])=[CH:18][CH:19]=2)[O:14][C:13](=[O:29])[CH:12]=1>>[Cl:1][C:2]1[CH:8]=[CH:7][CH:6]=[C:5]([CH3:9])[C:3]=1[NH:4][C:11]1[C:20]2[C:15](=[C:16]([O:23][CH:24]3[CH2:28][CH2:27][CH2:26][CH2:25]3)[C:17]([O:21][CH3:22])=[CH:18][CH:19]=2)[O:14][C:13](=[O:29])[CH:12]=1참가 물질
3
실험 절차
The title compound was prepared from 2-chloro-6-methylaniline and 4-chloro-8-(cyclopentyloxy)-7-methoxy-2H-chromen-2-one following the procedure outlined in Example 16. 1H NMR (400 MHz, DMSO-d6): δ 9.18 (s, 1H), 7.94 (d, 1H), 7.50 (dd, 1H), 7.42-7.34 (m, 2H), 7.16 (d, 1H), 4.82 (m, 1H), 4.28 (s, 1H), 3.90 (s, 3H), 2.21 (s, 3H), 1.90-1.45 (m, 8H); MS (ESI): 399.9.
출처 및 근거
- ORD 기록
- ord-d331dba622994f2ebe5cd5cf27577b80
- 출처 데이터셋
- uspto-grants-2010_06
- 특허 번호
- US07745646B2
연결된 노트
불러오는 중…